Profile data is unavailable for this security.
About the company
Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of medical device products. The Company operates its businesses through six segments. The Medical Device Products segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in HKD (TTM)14.88bn
- Net income in HKD2.24bn
- Incorporated2000
- Employees13.06k
- LocationShandong Weigao Group Medical Polymer Co Ltd1 Weigao RoadTorch Hi-tech Science ParkWEIHAI 264210ChinaCHN
- Phone+86 6 315621999
- Fax+86 6 315621999
- Websitehttps://www.weigaoholding.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angelalign Technology Inc | 2.42bn | 184.50m | 12.35bn | 3.54k | 66.36 | 3.33 | 40.25 | 5.09 | 1.09 | 1.09 | 14.32 | 21.73 | 0.4195 | 6.80 | 8.48 | 678,086.00 | 2.99 | 4.48 | 4.10 | 5.73 | 62.52 | 63.83 | 7.13 | 11.67 | 2.69 | -- | 0.1587 | -- | 28.23 | 23.51 | 60.88 | 3.98 | 14.40 | -- |
| MicroPort Scientific Corp | 7.96bn | -1.28bn | 19.23bn | 6.29k | -- | 3.82 | -- | 2.42 | -0.6958 | -0.6958 | 4.33 | 2.63 | 0.2694 | 1.23 | 3.24 | 1,254,049.00 | -5.23 | -11.96 | -9.45 | -19.14 | 54.13 | 59.67 | -19.43 | -48.95 | 1.15 | -1.63 | 0.5981 | -- | 8.45 | 5.38 | 55.19 | -- | -1.87 | -- |
| QingSong Health Corp | 1.41bn | 90.99m | 19.67bn | 205.00 | 216.14 | -- | 203.98 | 13.96 | 0.4409 | 0.4409 | 6.83 | -6.20 | -- | -- | -- | 7,226,975.00 | -- | -- | -- | -- | 32.06 | -- | 6.46 | -- | -- | -- | 3.27 | -- | 92.87 | -- | -90.75 | -- | -- | -- |
| Shandong Weigao Group Medical Polymer Co | 14.81bn | 2.23bn | 21.78bn | 13.06k | 9.87 | 0.8049 | 6.29 | 1.47 | 0.4874 | 0.4874 | 3.24 | 5.98 | 0.3705 | 2.87 | 2.05 | 1,164,585.00 | 5.85 | 7.58 | 7.38 | 9.83 | 49.69 | 52.81 | 15.78 | 18.24 | 3.32 | 16.68 | 0.1766 | 33.39 | -1.08 | 4.74 | 3.24 | 2.24 | -8.05 | 13.11 |
| Shenzhen Edge Medical Co Ltd | 315.73m | -197.98m | 23.36bn | -- | -- | 17.25 | -- | 73.98 | -0.5106 | -0.5106 | 0.8143 | 3.46 | -- | -- | -- | -- | -- | -- | -- | -- | 61.90 | -- | -62.70 | -- | 10.86 | -- | 0.0114 | -- | 233.03 | -- | -2.65 | -- | -- | -- |
| Shanghai MicroPort MedBot Group Co Ltd | 377.45m | -541.34m | 24.63bn | 440.00 | -- | 40.69 | -- | 65.25 | -0.5503 | -0.5503 | 0.3799 | 0.5869 | 0.2545 | 1.11 | 7.18 | 838,782.70 | -36.76 | -42.31 | -62.94 | -52.87 | 33.18 | 28.11 | -144.46 | -936.40 | 1.45 | -26.62 | 0.5653 | -- | 145.95 | -- | 36.53 | -- | 62.90 | -- |
| Shanghai Conant Optical Co Ltd | 2.45bn | 556.98m | 29.48bn | 2.95k | 46.12 | 9.81 | 45.54 | 12.02 | 1.26 | 1.26 | 5.57 | 5.93 | 0.7988 | 2.46 | 5.61 | 900,818.90 | 18.14 | 14.77 | 23.71 | 20.63 | 39.52 | 36.69 | 22.71 | 16.80 | 2.79 | -- | 0.0845 | 19.94 | 17.11 | 14.25 | 30.96 | 30.79 | 31.32 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 22 May 2025 | 190.61m | 4.22% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 150.68m | 3.33% |
| BlackRock Fund Advisorsas of 29 Jan 2026 | 111.44m | 2.46% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 100.83m | 2.23% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 70.51m | 1.56% |
| ARGA Investment Management LPas of 31 Oct 2025 | 60.62m | 1.34% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 46.42m | 1.03% |
| State Street Global Advisors Ltd.as of 05 Feb 2026 | 45.18m | 1.00% |
| Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 40.12m | 0.89% |
| BlackRock Financial Management, Inc.as of 29 Jan 2026 | 39.89m | 0.88% |
